More on BRKR
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $38.50 |
|
|||
| Open | $37.78 | ||||
| 52 Wk High | $29.85 | ||||
| 52 Wk Low | $19.59 | ||||
| Day High | $38.50 | ||||
| Day Low | $36.52 | ||||
| P/E | 76.42 | ||||
| EPS | $0.48 | ||||
| Volume | 1,727,076 | ||||
- Form SCHEDULE 13G/A BRUKER CORP Filed by: ORBIS INVESTMENT MANAGEMENT LTD
- Form S-8 POS BRUKER CORP
- Form S-8 BRUKER CORP
- Form 10-K BRUKER CORP For: Dec 31
- Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
- Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
- Bruker launches CellScape XR proteomics platform, opens PaintScape pre-orders
- Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
- Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
- Form 8-K BRUKER CORP For: Feb 20
Entities mentioned with BRKR
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
